These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 30124813)

  • 1. Detrimental Effect of Broad-spectrum Antibiotics on Intestinal Microbiome Diversity in Patients After Allogeneic Stem Cell Transplantation: Lack of Commensal Sparing Antibiotics.
    Weber D; Hiergeist A; Weber M; Dettmer K; Wolff D; Hahn J; Herr W; Gessner A; Holler E
    Clin Infect Dis; 2019 Apr; 68(8):1303-1310. PubMed ID: 30124813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rifaximin preserves intestinal microbiota balance in patients undergoing allogeneic stem cell transplantation.
    Weber D; Oefner PJ; Dettmer K; Hiergeist A; Koestler J; Gessner A; Weber M; Stämmler F; Hahn J; Wolff D; Herr W; Holler E
    Bone Marrow Transplant; 2016 Aug; 51(8):1087-92. PubMed ID: 26999466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbiota Disruption Induced by Early Use of Broad-Spectrum Antibiotics Is an Independent Risk Factor of Outcome after Allogeneic Stem Cell Transplantation.
    Weber D; Jenq RR; Peled JU; Taur Y; Hiergeist A; Koestler J; Dettmer K; Weber M; Wolff D; Hahn J; Pamer EG; Herr W; Gessner A; Oefner PJ; van den Brink MRM; Holler E
    Biol Blood Marrow Transplant; 2017 May; 23(5):845-852. PubMed ID: 28232086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease.
    Holler E; Butzhammer P; Schmid K; Hundsrucker C; Koestler J; Peter K; Zhu W; Sporrer D; Hehlgans T; Kreutz M; Holler B; Wolff D; Edinger M; Andreesen R; Levine JE; Ferrara JL; Gessner A; Spang R; Oefner PJ
    Biol Blood Marrow Transplant; 2014 May; 20(5):640-5. PubMed ID: 24492144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gut microbiota and graft-versus-host disease: broad-spectrum antibiotic use increases post-allogeneic hematopoietic stem cell transplant graft-versus-host disease-related mortality].
    Shono Y
    Rinsho Ketsueki; 2017; 58(7):835-842. PubMed ID: 28781282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of the Intestinal Microbiota by Broad-Spectrum Antibiotic Use Correlates with the Occurrence of Intestinal Graft-versus-Host Disease.
    Lee SE; Lim JY; Ryu DB; Kim TW; Park SS; Jeon YW; Yoon JH; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Cho SG; Kim DW; Lee JW; Kim CS; Shin DM; Min CK
    Biol Blood Marrow Transplant; 2019 Oct; 25(10):1933-1943. PubMed ID: 31195137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restrictive Versus Permissive Use of Broad-spectrum Antibiotics in Patients Receiving Allogeneic Stem Cell Transplantation and With Early Fever Due to Cytokine Release Syndrome: Evidence for Beneficial Microbiota Protection Without Increase in Infectious Complications.
    Weber D; Hiergeist A; Weber M; Ghimire S; Salzberger B; Wolff D; Poeck H; Gessner A; Edinger M; Herr W; Meedt E; Holler E
    Clin Infect Dis; 2023 Nov; 77(10):1432-1439. PubMed ID: 37386935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged Suppression of Butyrate-Producing Bacteria Is Associated With Acute Gastrointestinal Graft-vs-Host Disease and Transplantation-Related Mortality After Allogeneic Stem Cell Transplantation.
    Meedt E; Hiergeist A; Gessner A; Dettmer K; Liebisch G; Ghimire S; Poeck H; Edinger M; Wolff D; Herr W; Holler E; Weber D
    Clin Infect Dis; 2022 Mar; 74(4):614-621. PubMed ID: 34043764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice.
    Shono Y; Docampo MD; Peled JU; Perobelli SM; Velardi E; Tsai JJ; Slingerland AE; Smith OM; Young LF; Gupta J; Lieberman SR; Jay HV; Ahr KF; Porosnicu Rodriguez KA; Xu K; Calarfiore M; Poeck H; Caballero S; Devlin SM; Rapaport F; Dudakov JA; Hanash AM; Gyurkocza B; Murphy GF; Gomes C; Liu C; Moss EL; Falconer SB; Bhatt AS; Taur Y; Pamer EG; van den Brink MRM; Jenq RR
    Sci Transl Med; 2016 May; 8(339):339ra71. PubMed ID: 27194729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiome and diversity indices during blood stem cells transplantation - new perspectives?
    Parco S; Benericetti G; Vascotto F; Palmisciano G
    Cent Eur J Public Health; 2019 Dec; 27(4):335-339. PubMed ID: 31951695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anaerobic Antibiotics and the Risk of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
    Tanaka JS; Young RR; Heston SM; Jenkins K; Spees LP; Sung AD; Corbet K; Thompson JC; Bohannon L; Martin PL; Stokhuyzen A; Vinesett R; Ward DV; Bhattarai SK; Bucci V; Arshad M; Seed PC; Kelly MS
    Biol Blood Marrow Transplant; 2020 Nov; 26(11):2053-2060. PubMed ID: 32682948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between acute graft-versus-host disease and antimicrobial peptide expression in the gastrointestinal tract after allogeneic stem cell transplantation.
    Weber D; Frauenschläger K; Ghimire S; Peter K; Panzer I; Hiergeist A; Weber M; Kutny D; Wolff D; Grube M; Huber E; Oefner P; Gessner A; Hehlgans T; Herr W; Holler E
    PLoS One; 2017; 12(9):e0185265. PubMed ID: 28934349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omitting Ciprofloxacin Prophylaxis in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation and Its Impact on Clinical Outcomes and Microbiome Structure.
    Daoud-Asfour H; Henig I; Ghersin I; Rakedzon S; Stern A; Pitashny M; Zuckerman T; Bar-Yoseph H
    Transplant Cell Ther; 2022 Mar; 28(3):168.e1-168.e8. PubMed ID: 34954293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between the incidence of intestinal graft-vs-host disease and antibiotic use after allogeneic hematopoietic stem cell transplantation.
    Hidaka D; Hayase E; Shiratori S; Hasegawa Y; Ishio T; Tateno T; Okada K; Goto H; Sugita J; Onozawa M; Nakagawa M; Kahata K; Endo T; Hashimoto D; Teshima T
    Clin Transplant; 2018 Sep; 32(9):e13361. PubMed ID: 30054935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic-Induced Depletion of Anti-inflammatory Clostridia Is Associated with the Development of Graft-versus-Host Disease in Pediatric Stem Cell Transplantation Patients.
    Simms-Waldrip TR; Sunkersett G; Coughlin LA; Savani MR; Arana C; Kim J; Kim M; Zhan X; Greenberg DE; Xie Y; Davies SM; Koh AY
    Biol Blood Marrow Transplant; 2017 May; 23(5):820-829. PubMed ID: 28192251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GPR Expression in Intestinal Biopsies From SCT Patients Is Upregulated in GvHD and Is Suppressed by Broad-Spectrum Antibiotics.
    Ghimire S; Weber D; Hippe K; Meedt E; Hoepting M; Kattner AS; Hiergeist A; Gessner A; Matos C; Ghimire S; Wolff D; Edinger M; Hoffmann P; Poeck H; Herr W; Holler E
    Front Immunol; 2021; 12():753287. PubMed ID: 34777363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiome: An Emerging New Frontier in Graft-Versus-Host Disease.
    Kumari R; Palaniyandi S; Hildebrandt GC
    Dig Dis Sci; 2019 Mar; 64(3):669-677. PubMed ID: 30523482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Multicenter Study of Bacterial Blood Stream Infections in Pediatric Allogeneic Hematopoietic Cell Transplantation Recipients: The Role of Acute Gastrointestinal Graft-versus-Host Disease.
    Satwani P; Freedman JL; Chaudhury S; Jin Z; Levinson A; Foca MD; Krajewski J; Sahdev I; Talekar MK; Gardenswartz A; Silverman J; Hayes M; Dvorak CC
    Biol Blood Marrow Transplant; 2017 Apr; 23(4):642-647. PubMed ID: 28104513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reg3α concentrations at day of allogeneic stem cell transplantation predict outcome and correlate with early antibiotic use.
    Weber D; Weber M; Meedt E; Ghimire S; Wolff D; Edinger M; Poeck H; Hiergeist A; Gessner A; Ayuk F; Roesler W; Wölfl M; Kraus S; Zeiser R; Bertrand H; Bader P; Ullrich E; Eder M; Gleich S; Young R; Herr W; Levine JE; Ferrara JLM; Holler E
    Blood Adv; 2023 Apr; 7(7):1326-1335. PubMed ID: 36350750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low urinary indoxyl sulfate levels early after transplantation reflect a disrupted microbiome and are associated with poor outcome.
    Weber D; Oefner PJ; Hiergeist A; Koestler J; Gessner A; Weber M; Hahn J; Wolff D; Stämmler F; Spang R; Herr W; Dettmer K; Holler E
    Blood; 2015 Oct; 126(14):1723-8. PubMed ID: 26209659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.